Infectious diseases specialist and leader of our remdesivir clinical trial, Dr. Andre Kalil, explains how we can most effectively return to living a normal life while in the midst of the COVID-19 pandemic. In less than a minute, he explains in simple terms how we can avoid a second shutdown or a second spike, by all working together.
- The REALITY of reopening - Nebraska Medicine ( Download)
- COVID-19: Vaccinating the community – Nebraska Medicine ( Download)
- Clinical trial begins for COVID-19 medication ( Download)
- A Message To The Community Regarding COVID-19 - Nebraska Medicine ( Download)
- Successful Treatment of COVID-19 at Nebraska Med ( Download)
- COVID-19: Minimizing Your Risk - Nebraska Medicine ( Download)
- COVID-19 Q&A: Who Is Most At Risk - Nebraska Medicine ( Download)
- Nebraska Doctors Announce First U.S. Clinal Drug Trial to Treat Coronavirus ( Download)
- COVID-19 survivor credits Nebraska Medicine clinical trial for saving his life ( Download)
- Remdesivir, world’s first drug to treat coronavirus disease gets approved ( Download)
- COVID-19: Easing fear and anxiety - Nebraska Medicine ( Download)
- FDA approves remdesivir as COVID-19 treatment ( Download)
- COVID-19 Treatments: Remdesivir ( Download)
- What is Remdesivir, and could it be a COVID-19 treatment Your coronavirus Q&A ( Download)
- WHO study says remdesivir did not reduce COVID-19 mortality rate: Report ( Download)
